Shalaby, M R <br/><br/>
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.  [electronic resource] 

 -  The Journal of experimental medicine  Jan 1992 
 - 217-25 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0022-1007 
<br/><br/><label>Standard No.: </label>10.1084/jem.175.1.217  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Antibodies, Monoclonal<br/>Antigens, CD--genetics<br/>Antigens, Differentiation, T-Lymphocyte--genetics<br/>Base Sequence<br/>Breast Neoplasms--immunology<br/>CD3 Complex<br/>Cloning, Molecular<br/>Cytotoxicity, Immunologic<br/>Female<br/>Flow Cytometry<br/>Genetic Variation<br/>Humans<br/>Models, Molecular<br/>Molecular Sequence Data<br/>Oligodeoxyribonucleotides<br/>Oligonucleotides, Antisense<br/>Polymerase Chain Reaction<br/>Protein Conformation<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogenes<br/>Receptor, ErbB-2<br/>Receptors, Antigen, T-Cell--genetics<br/>Sequence Homology, Nucleic Acid<br/>T-Lymphocytes, Cytotoxic--immunology